Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations

Clinical Lung Cancer

Volumn 14, Issue 4, 2013, Pages 452-456

  Thomas, Anish ^a   Xi, Liqiang ^a   Carter, Corey A ^b   Rajan, Arun ^a   Khozin, Sean ^a   Szabo, Eva ^a   Dennis, Phillip A ^a   Giaccone, Giuseppe ^a   Raffeld, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Concurrent mutations; Familial lung cancer; Germline EGFR mutations; KRAS mutation; Lung cancer prevention

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; METHIONINE; PEMETREXED; RAPAMYCIN; THREONINE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CODON; COMPUTER ASSISTED TOMOGRAPHY; EXON; FEMALE; GAIN OF FUNCTION MUTATION; GENE MUTATION; GENETIC SCREENING; GERM LINE; HUMAN; IMAGE ANALYSIS; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; MOLECULAR MECHANICS; POINT MUTATION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; COMBINED MODALITY THERAPY; DNA, NEOPLASM; FEMALE; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PEDIGREE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84878807277     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.01.005     Document Type: Article

References (15)

1. Y. Gao, A.M. Goldstein, D. Consonni Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer Int J Cancer 125 2009 146 152
2. P. Yang, Y.F. Li, R.X. Jiang A rigorous and comprehensive validation: common genetic variations and lung cancer Cancer Epidemiol Biomarkers Prev 19 2010 240 244
3. D.R. Aberle, A.M. Adams, C.D. Berg Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
4. D.W. Bell, I. Gore, R.A. Okimoto Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR Nat Genet 37 2005 1315 1316
5. H. Vikis, M. Sato, M. James EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity Cancer Res 67 2007 4665 4670
6. L. Prudkin, X. Tang, I.I. Wistuba Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer J Thorac Oncol 4 2009 139 141
7. N. Girard, E. Lou, C.G. Azzoli Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report Clin Cancer Res 16 2010 755 763
8. C. Tibaldi, E. Giovannetti, E. Vasile Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients J Thorac Oncol 6 2011 395 396
9. G.R. Oxnard, V.A. Miller, M.E. Robson Screening for germline EGFR T790M mutations through lung cancer genotyping J Thorac Oncol 7 2012 1049 1052
10. S. Kobayashi, T.J. Boggon, T. Dayaram EGFR mutation and resistance of non-small-cell lung cancer to gefitinib N Engl J Med 352 2005 786 792
11. W. Pao, V.A. Miller, K.A. Politi Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain PLoS Med 2 2005 225 235
12. M. Inukai, S. Toyooka, S. Ito Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer Cancer Res 66 2006 7854 7858
13. L. Regales, M.N. Balak, Y. Gong Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors PLoS ONE 2 2007 e810
14. B.J. Skaggs, M.E. Gorre, A. Ryvkin Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant bcr-abl mutants Proc Natl Acad Sci U S A 103 2006 19466 19471
15. K. Suda, R. Onozato, Y. Yatabe EGFR T790M mutation: a double role in lung cancer cell survival? J Thorac Oncol 4 2009 1 4